Obesity Drug Set to Exceed Ozempic With $27B Sales by 2029
Mounjaro, a weight loss medication, is projected to outpace Ozempic, driven by convincing clinical results and anticipated sales of $27 billion by 2029.
Source: medindia.net
Page 4 - Pharma Analyst News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Pharma Analyst. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Pharma Analyst Today - Breaking & Trending Today
Obesity drug Mounjaro to surpass Ozempic with $27 bn sales in 2029: Report
Eli Lilly's Mounjaro is poised to surpass Novo Nordisk's Ozempic (semaglutide) and become the leading drug by sales in the obesity and diabetes market, according to a report on Monday.Ozempic took the weight loss sector by storm in 2023, ...
Source: prokerala.com
GlobalData : Insomnia treatment market faces need for innovation as Z-drugs show limitations, says GlobalData -October 04, 2023 at 08:36 am EDT
04 Oct, 2023 Insomnia treatment market faces need for innovation as Z-drugs show limitations, says GlobalData Share Print...
Source: marketscreener.com
GlobalData : Intercept acquisition by Alfasigma reflects NASH failure, says GlobalData -September 28, 2023 at 02:02 am EDT
28 Sep, 2023 Intercept acquisition by Alfasigma reflects NASH failure, says GlobalData Share Print page ...
Source: marketscreener.com
Psychedelic drug market set to reach $7.2 billion in 2029: Report
The psychedelic drug market is on the brink of extraordinary growth, projected to soar to $7.2 billion by 2029, reflecting a robust 55 per cent compound annual growth rate (CAGR), according to a report on Monday.This ascent is propelled by ...
Source: prokerala.com